H.R. 4822
Reported by CommitteeHealth Care Price Transparency Act of 2023
Latest Action
Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-231, Part I.
9/29/2023 • House
Summary
Congress.gov has not published an official summary of this bill yet.
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (1)
Sponsor
No cosponsors yet
Cosponsors may be added as the bill moves through Congress
Bill Journey
Originated in the House
Introduced
July 24, 2023
Committee Review
July 26, 2023
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 25 - 16.
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Committee Reports (1)
Related Bills (9)
H.R. 2679
Pharmacy Benefits Manager Accountability Act
H.R. 3237
To amend title XVIII of the Social Security Act to require each off-campus outpatient department of a provider to include a unique identifier on claims for items and services, and to require providers with a department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each such department.
H.R. 4881
To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.
H.R. 4882
Clinical Laboratory Price Transparency Act of 2023
H.R. 4883
Medicare Common Ownership Transparency Act of 2023
H.R. 4905
Health Insurance Price Transparency Act of 2023
H.R. 4828
Imaging Services Price Transparency Act of 2023
H.R. 4839
Hospital and ASC Price Transparency Act of 2023
H.R. 4846
Better Deals and Lower Prices Act